Posted by kinasepro on June 19, 2007
Motesanib diphosphate, AMG-706 hits: Vegfr1,2,3, c-kit, Pdgfr-b, and Ret
Clinic Ph iii: NSCLC
Cancer Res.; WO/2002/066470
This entry was posted on June 19, 2007 at 12:37 am and is filed under Amgen, c-Kit, PDGFR, Phase III, VEGF.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
Fill in your details below or click an icon to log in:
You are commenting using your WordPress.com account. ( Log Out / Change )
You are commenting using your Twitter account. ( Log Out / Change )
You are commenting using your Facebook account. ( Log Out / Change )
You are commenting using your Google+ account. ( Log Out / Change )
Connecting to %s
Notify me of new comments via email.